News | News By Subject | News by Disease News By Date | Search News

Liver cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Bristol-Myers Squibb (BMY) Slams Down $100 Million to Make a Play Into NASH     11/14/2016
Galectin (GALT) Stock Craters After Phase IIa NASH Failure     9/28/2016
Bayer (BAY)'s Regorafenib Extends Lives of Liver Cancer Patients in Late Stage Study     5/5/2016
The Three Most Important Drugs in Gilead (GILD)'s Pipeline     12/8/2015
Raptor (RPTP)'s Phase IIb CyNCh Study Fails To Meet Primary Endpoint, Shares Skid     9/15/2015
AbbVie (ABBV)’s Viekira Pak Clears Another Hurdle, 100% HCV-1b Clearance Rate in Phase III Trial     6/25/2015
La Jolla Pharma (LJPC) Bails On Two Drug Programs, Shifts Focus to Rare Disease     5/11/2015
Conatus Pharma Shares Soar On Successful Emricasan Phase II Results     3/27/2015
Nektar Therapeutics (NKTR) Cancer Drug Improves Survival But Misses Primary Endpoint, As Watchers Worry     3/20/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Tekmira (TKMR) Announces $24.5M Licensing And Collaboration Agreement With Dicerna Pharmaceuticals (DRNA)     11/17/2014
Ocera Therapeutics, Inc. (OCRX)’s New HE Drug Could Pull Stock Up Out Of Rut: Cowen     10/24/2014
Gilead Sciences, Inc. (GILD) Will Have Higher Revenues, EPS On Liver Drug Strength: Citi     10/9/2014

News from Around the Web
Excess Weight Linked To 8 More Cancers, Washington University School of Medicine Reveals     8/31/2016
Broccoli May Protect Against Liver Cancer, University of Illinois Study Shows     3/4/2016
Nanoparticle Therapy That Uses LDL And Fish Oil Kills Liver Cancer Cells, UT Southwestern Medical Center Study     2/9/2016
Studying Cancer DNA In Blood May Help Personalize Treatment In Liver Cancer, Hiroshima University Reveals     11/3/2015
Prolonged TV Watching Linked To Eight Leading Causes Of Death, American Journal of Preventive Medicine Publishes     10/28/2015
Could Image Mapping Offer Way To Do Noninvasive Liver Biopsies?     10/20/2015
New DNA Testing For Liver Cancer Could Improve Survival, Hiroshima University Study     9/11/2015
Citrus Scent Could Help Fight Liver Cancer, Ruhr-University Study     1/21/2015
Herbal Medicines Could Contain Dangerous Levels Of Toxic Mold, University Of Peshawar     10/27/2014
A Genetic Catch-22 Promotes and Prevents Liver Cancer, University of Southern California Study     8/7/2013
Breakthrough Chemo Bath Treats Liver Cancer for First Time in UK, Southampton General Hospital Reveals     11/12/2012
Metabolic Syndrome Increases Risk of Both Major Types of Primary Liver Cancer, National Cancer Institute Study     7/28/2011
Experts at University of Hong Kong Find Rogue Stem Cells in Liver Cancer     7/7/2011
Six-Year Study Confirms Australia's Sirtex Medical's Liver Cancer Therapy is Safe and Effective     7/7/2011
Discovery in Liver Cancer Cells Provides New Target for Drugs, Virginia Commonwealth University Study     3/23/2011

Press Releases
A*STAR Release: Doctors A Step Closer To Giving Liver Cancer Patients A More Precise Treatment     3/16/2017
twoXAR Announces Preclinical Proof-of-Concept Data On Novel Liver Cancer Candidate     3/14/2017
ArQule (ARQL), Daiichi Sankyo's Liver Cancer Drug Comes Up Short in Another Phase III Study     2/17/2017
Trek Therapeutics Announces Oral Presentation Of Faldaprevir, TD-6450 And Ribavirin Ph2a Trial Results At The Asian Pacific Association For The Study Of The Liver On February 18, 2017 In Shanghai     2/13/2017
Immuron Announces First Patient Enrolled In Pediatric Fatty-Liver Phase II Trial     2/7/2017
4SC (VSC.F) Release: Overall Survival Benefit For Resminostat In First-Line Liver Cancer Study Subgroup     1/26/2017
Eisai Inc. (ESALF.PK) Release: Positive Topline Results Of Large Phase 3 Trial Show Pharma's Lenvatinib Meets Primary Endpoint In Unresectable Hepatocellular Carcinoma     1/25/2017
Onxeo Release: Company Completes Enrollment In Phase 3 Study Of Livatag For The Treatment Of Hepatocellular Carcinoma     1/24/2017
FDA Grants Bayer (BAY) Priority Review For Stivarga (Regorafenib) For The Second-Line Systemic Treatment Of Liver Cancer     1/4/2017
Nanobiotix Reports Positive Phase I/II Preliminary Data On Feasibility And Safety Of NBTXR3 In Liver Cancers Trial     12/15/2016
BTG International Canada Release; Canada First To Receive New Treatment Option For Liver Cancer Patients     12/5/2016
Mallinckrodt (MNK) Release: Clinical Data Analysis On Terlipressin Presented At The Liver Meeting     11/17/2016
American Medical Association's USAN & WHO's INN Approve "Namodenoson" As Generic Name For Can-Fite BioPharma (CFBI)'s Liver Drug CF102     11/16/2016
Bayer (BAY) Submits Supplemental New Drug Application For Stivarga (regorafenib) For Advanced Liver Cancer     11/7/2016
Medivir (MVRBF)’s Nucleotide Polymerase Inhibitor For The Treatment Of Liver Cancer, MIV-818, Enters Non-Clinical Development     11/1/2016